• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提供一种快速将总剂量转换为混合种子近距离治疗的生物有效剂量(BED)的方法。

Providing a fast conversion of total dose to biological effective dose (BED) for hybrid seed brachytherapy.

机构信息

Radiation Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

出版信息

J Appl Clin Med Phys. 2012 Sep 6;13(5):3800. doi: 10.1120/jacmp.v13i5.3800.

DOI:10.1120/jacmp.v13i5.3800
PMID:22955644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5718217/
Abstract

Optimization of permanent seed implant brachytherapy plans for treatment of prostate cancer should be based on biological effective dose (BED) distributions, since dose does not accurately represent biological effects between different types of sources. Currently, biological optimization for these plans is not feasible due to the amount of time necessary to calculate the BED distribution. This study provides a fast calculation method, based on the total dose, to calculate the BED distribution. Distributions of various numbers of hybrid seeds were used to calculate total dose distributions, as well as BED distributions. Hybrid seeds are a mixture of different isotopes (in this study (125)I and (103)Pd). Three ratios of hybrid seeds were investigated: 25/75, 50/50, and 75/25. The total dose and BED value from each voxel were coupled together to produce graphs of total dose vs. BED. Equations were then derived from these graphs. The study investigated four types of tissue: bladder, rectum, prostate, and other normal tissue. Equations were derived from the total dose - BED correspondence. Accuracy of conversion from total dose to BED was within 2 Gy; however, accuracy of conversion was found to be better for high total dose regions as compared to lower dose regions. The method introduced in this paper allows one to perform fast conversion of total dose to BED for brachytherapy using hybrid seeds, which makes the BED-based plan optimization practical. The method defined here can be extended to other ratios, as well as other tissues that are affected by permanent seed implant brachytherapy (i.e., breast).

摘要

优化前列腺癌永久性种子植入近距离放疗计划应基于生物有效剂量(BED)分布,因为剂量不能准确代表不同类型源之间的生物学效应。目前,由于计算 BED 分布所需的时间量,这些计划的生物学优化是不可行的。本研究提供了一种快速计算方法,基于总剂量来计算 BED 分布。使用各种数量的混合种子分布来计算总剂量分布以及 BED 分布。混合种子是不同同位素的混合物(在本研究中为(125)I 和(103)Pd)。研究了三种混合种子的比例:25/75、50/50 和 75/25。每个体素的总剂量和 BED 值被耦合在一起,生成总剂量与 BED 的关系图。然后从这些图中推导出方程。该研究调查了四种组织:膀胱、直肠、前列腺和其他正常组织。从总剂量-BED 对应关系中推导出方程。从总剂量转换为 BED 的转换精度在 2 Gy 以内;然而,与低剂量区域相比,发现高总剂量区域的转换精度更好。本文介绍的方法允许使用混合种子快速将总剂量转换为 BED 进行近距离放疗,从而使基于 BED 的计划优化成为可能。此处定义的方法可以扩展到其他比例以及受永久性种子植入近距离放疗影响的其他组织(例如,乳房)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/3d49c02cb0f4/ACM2-13-024-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/c61acdfd05a2/ACM2-13-024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/f230f447ee55/ACM2-13-024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/44dcc1e68689/ACM2-13-024-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/52fdc297c561/ACM2-13-024-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/3d49c02cb0f4/ACM2-13-024-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/c61acdfd05a2/ACM2-13-024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/f230f447ee55/ACM2-13-024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/44dcc1e68689/ACM2-13-024-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/52fdc297c561/ACM2-13-024-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f55/5718217/3d49c02cb0f4/ACM2-13-024-g005.jpg

相似文献

1
Providing a fast conversion of total dose to biological effective dose (BED) for hybrid seed brachytherapy.提供一种快速将总剂量转换为混合种子近距离治疗的生物有效剂量(BED)的方法。
J Appl Clin Med Phys. 2012 Sep 6;13(5):3800. doi: 10.1120/jacmp.v13i5.3800.
2
Calculating prescription doses for new sources by biologically effective dose matching.
Brachytherapy. 2012 Nov-Dec;11(6):521-7. doi: 10.1016/j.brachy.2012.02.003. Epub 2012 Mar 19.
3
Inverse planning optimization for hybrid prostate permanent-seed implant brachytherapy plans using two source strengths.使用两种源强对混合前列腺永久种子植入近距离放疗计划进行逆向计划优化。
J Appl Clin Med Phys. 2010 Jun 3;11(3):3096. doi: 10.1120/jacmp.v11i3.3096.
4
Biologically effective dose (BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives.含不同半衰期放射性核素混合物的组织间籽源植入的生物有效剂量(BED)
Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):825-34. doi: 10.1016/s0360-3016(02)04282-7.
5
Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans.在优化的碘-125前列腺植入治疗计划中,剂量均匀性作为源活度的函数。
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1120-30. doi: 10.1016/s0360-3016(01)01802-8.
6
Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.低能量近距离放射治疗蒙特卡罗剂量计算对人体组织成分不确定性的敏感性。
Med Phys. 2010 Oct;37(10):5188-98. doi: 10.1118/1.3477161.
7
Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.意大利七家机构间永久性间质内前列腺近距离放射治疗植入后评估的比较研究。
Radiother Oncol. 2004 Apr;71(1):13-21. doi: 10.1016/j.radonc.2004.02.006.
8
The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.在多种种子数量、活度和设计情况下,¹²⁵I永久性籽源植入剂量分布对位移和迁移的稳健性。
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1298-308. doi: 10.1016/j.ijrobp.2003.11.016.
9
Intraoperative dynamic dose optimization in permanent prostate implants.永久性前列腺植入术中的术中动态剂量优化
Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):854-61. doi: 10.1016/s0360-3016(03)00291-8.
10
Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.¹⁰³Pd和¹²⁵I前列腺植入中籽源各向异性和籽源间衰减的剂量学效应
Med Phys. 2005 Aug;32(8):2557-66. doi: 10.1118/1.1897466.

引用本文的文献

1
Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity.通过整合调强放射治疗(IMRT)和低剂量率前列腺近距离放射治疗剂量测定法来确定联合治疗模式的剂量学约束及其与毒性的相关性。
Adv Radiat Oncol. 2022 Dec 29;8(3):101156. doi: 10.1016/j.adro.2022.101156. eCollection 2023 May-Jun.
2
Biological effective dose in analysis of rectal dose in prostate cancer patients who underwent a combination therapy of VMAT and LDR with hydrogel spacer insertion.分析 VMAT 和 LDR 联合治疗并插入水凝胶间隔器的前列腺癌患者直肠剂量时的生物有效剂量。
J Appl Clin Med Phys. 2022 Jun;23(6):e13584. doi: 10.1002/acm2.13584. Epub 2022 Mar 14.
3

本文引用的文献

1
Calculating prescription doses for new sources by biologically effective dose matching.
Brachytherapy. 2012 Nov-Dec;11(6):521-7. doi: 10.1016/j.brachy.2012.02.003. Epub 2012 Mar 19.
2
Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.向前列腺癌的焦点治疗迈进:双同位素永久性种子植入作为一种可能的解决方案。
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):297-304. doi: 10.1016/j.ijrobp.2010.10.060. Epub 2011 Apr 30.
3
AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.AAPM 关于前列腺癌永久性间质近距离放射治疗剂量处方和报告方法的建议:第 137 任务组报告。
[Long-term outcomes of two different treatment concepts with HDR brachytherapy boost for intermediate-risk prostate cancer].
[两种不同治疗方案采用高剂量率近距离放疗加量治疗中危前列腺癌的长期疗效]
Strahlenther Onkol. 2016 Mar;192(3):196-8. doi: 10.1007/s00066-015-0937-9.
Med Phys. 2009 Nov;36(11):5310-22. doi: 10.1118/1.3246613.
4
Generation of composite dose and biological effective dose (BED) over multiple treatment modalities and multistage planning using deformable image registration.使用可变形图像配准在多种治疗方式和多阶段计划中生成复合剂量和生物等效剂量(BED)
Med Dosim. 2010 Summer;35(2):143-50. doi: 10.1016/j.meddos.2009.05.001. Epub 2009 Jun 6.
5
More accurate fitting of 125I and 103Pd radial dose functions.125I和103Pd径向剂量函数的更精确拟合。
Med Phys. 2008 Sep;35(9):4242-50. doi: 10.1118/1.2964097.
6
Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.比较动态调强放射治疗(dIMRT)与三维适形放射治疗(3DCRT)的两种策略在高危前列腺癌大分割治疗中的应用。
Radiat Oncol. 2008 Jan 7;3:1. doi: 10.1186/1748-717X-3-1.
7
Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model.通过将正常组织耐受剂量最佳拟合到线性二次模型的正常组织并发症概率(NTCP)方程中来估计正常组织并发症概率的分析方法。
J Cancer Res Ther. 2005 Jul-Sep;1(3):168-79. doi: 10.4103/0973-1482.19597.
8
Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy.正常膀胱和直肠亚致死性损伤修复的中场休息时间:来自宫颈近距离治疗的临床数据分析
Phys Med Biol. 2006 Aug 21;51(16):4063-71. doi: 10.1088/0031-9155/51/16/012. Epub 2006 Aug 2.
9
Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.低剂量率近距离放射治疗在膀胱癌治疗方面优于高剂量率近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):696-705. doi: 10.1016/j.ijrobp.2003.11.040.
10
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.美国医学物理学家协会第43任务组报告更新:用于近距离放射治疗剂量计算的修订版美国医学物理学家协会协议。
Med Phys. 2004 Mar;31(3):633-74. doi: 10.1118/1.1646040.